Trial · NCT04908189
Results by group262
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 262
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Number of Participants Meeting American College of Rheumatology (ACR) 20 at Week 16 | Deucravacitinib | 169 | Participants | ||
| Number of Participants Meeting American College of Rheumatology (ACR) 20 at Week 16 | Placebo | 123 | Participants | ||
| Change From Baseline in Disease Activity Score 28 C-reactive Protein (DAS28-CRP) at Week 16 | Deucravacitinib | -1.3133 | Standard Deviation 1.17420 | score on a scale | |
| Change From Baseline in Disease Activity Score 28 C-reactive Protein (DAS28-CRP) at Week 16 | Placebo | -0.9095 | Standard Deviation 1.10470 | score on a scale | |
| Change From Baseline in Health Assessment Quiestionnaire - Disability Index (HAQ-DI) at Week 16 | Deucravacitinib | -0.3103 | Standard Deviation 0.46159 | score on a scale | |
| Change From Baseline in Health Assessment Quiestionnaire - Disability Index (HAQ-DI) at Week 16 | Placebo | -0.2219 | Standard Deviation 0.46858 | score on a scale | |
| Number of Participants Meeting Psoriasis Area and Severity Index 75 (PASI 75) at Week 16 | Deucravacitinib | 63 | Participants | ||
| Number of Participants Meeting Psoriasis Area and Severity Index 75 (PASI 75) at Week 16 | Placebo | 23 | Participants | ||
| Change From Baseline in the 36-item Short Form (SF-36) Physical Component Summary (PCS) Score at Week 16 | Deucravacitinib | 6.194 | Standard Deviation 7.4640 | Score on a scale | |
| Change From Baseline in the 36-item Short Form (SF-36) Physical Component Summary (PCS) Score at Week 16 | Placebo | 4.262 | Standard Deviation 7.0328 | Score on a scale | |
| Number of Participants Meeting Enthesitis Resolution (Score of 0) Among Participants With Enthesitis at Baseline by Leeds Enthesitis Index (LEI) at Week 16 | Deucravacitinib | 74 | Participants | ||
| Number of Participants Meeting Enthesitis Resolution (Score of 0) Among Participants With Enthesitis at Baseline by Leeds Enthesitis Index (LEI) at Week 16 | Placebo | 66 | Participants | ||
| Number of Participants Meeting Achievement of Minimal Disease Activity (MDA) at Week 16 | Deucravacitinib | 80 | Participants | ||
| Number of Participants Meeting Achievement of Minimal Disease Activity (MDA) at Week 16 | Placebo | 46 | Participants | ||
| Change From Baseline in Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-Fatigue) Score at Week 16 | Deucravacitinib | 2.6 | Standard Deviation 8.17 | Score on a scale | |
| Change From Baseline in Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-Fatigue) Score at Week 16 | Placebo | 1.9 | Standard Deviation 8.54 | Score on a scale | |
| Number of Participants Meeting Dactylitis Resolution at Week 16 | Deucravacitinib | 43 | Participants | ||
| Number of Participants Meeting Dactylitis Resolution at Week 16 | Placebo | 36 | Participants | ||
| Number of Participants Meeting American College of Rheumatology (ACR) 50 at Week 16 | Deucravacitinib | 90 | Participants | ||
| Number of Participants Meeting American College of Rheumatology (ACR) 50 at Week 16 | Placebo | 51 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT04908189/results